Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
6.55
-0.24 (-3.53%)
Apr 28, 2026, 3:00 PM CST

SHA:600223 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8952,9481,7344,3185,139
Cash & Short-Term Investments
2,8952,9481,7344,3185,139
Cash Growth
-1.79%70.04%-59.85%-15.97%1.27%
Accounts Receivable
509.05511.85599.06428.31306.23
Other Receivables
47.6731.673,0621,3071,226
Receivables
556.72543.523,6611,7401,532
Inventory
437.16558.71525.4446,04748,204
Prepaid Expenses
00.08-491.91608.15
Other Current Assets
94.0793.4764.023,0323,187
Total Current Assets
3,9834,1445,98455,62958,670
Property, Plant & Equipment
1,1991,1921,2031,3821,345
Long-Term Investments
187.84168.53191.76926.97874.1
Goodwill
153.74153.74153.74155.59160.33
Other Intangible Assets
168.02163.22148.7196.5210.1
Long-Term Deferred Tax Assets
27.6129.8223.66105.04101.25
Long-Term Deferred Charges
84.0491.1153.9652.3440.51
Other Long-Term Assets
54.2658.7358.2626.2213.92
Total Assets
5,8586,0007,81858,47461,415
Accounts Payable
289.39413.35452.989,2668,694
Accrued Expenses
139.48136.53127.321,003948.47
Short-Term Debt
121.05212.12705.222,2703,219
Current Portion of Long-Term Debt
1.0112.51790.343,2222,307
Current Portion of Leases
4.599.218.165.681.99
Current Income Taxes Payable
19.0816.359.5226.5918.81
Current Unearned Revenue
112.01122.97108.4417,86921,686
Other Current Liabilities
159.52183.3199.7816,94414,217
Total Current Liabilities
846.131,1062,40250,60651,093
Long-Term Debt
644.55665.042,2153,751
Long-Term Leases
4.297.5312.9821.377.69
Long-Term Unearned Revenue
51.8151.2355.1855.6359.17
Long-Term Deferred Tax Liabilities
1.892.312.738.555.24
Total Liabilities
910.121,2123,13852,90754,916
Common Stock
1,0171,0171,0171,0171,009
Additional Paid-In Capital
614.02612.86612.51617.8616.38
Retained Earnings
2,6022,4752,3852,0822,202
Comprehensive Income & Other
--0.290.33900
Total Common Equity
4,2334,1054,0153,7174,727
Minority Interest
714.95683.47665.371,8501,773
Shareholders' Equity
4,9484,7884,6805,5676,500
Total Liabilities & Equity
5,8586,0007,81858,47461,415
Total Debt
136.94285.922,1827,7359,287
Net Cash (Debt)
2,7582,662-448.16-3,417-4,149
Net Cash Growth
3.62%----
Net Cash Per Share
2.642.62-0.44-3.01-4.01
Filing Date Shares Outstanding
1,0171,0171,0171,0171,009
Total Common Shares Outstanding
1,0171,0171,0171,0171,009
Working Capital
3,1373,0373,5835,0237,577
Book Value Per Share
4.164.043.953.663.79
Tangible Book Value
3,9113,7883,7123,3654,357
Tangible Book Value Per Share
3.853.733.653.313.43
Buildings
1,0891,0459171,3121,294
Machinery
738.73681.06620.81604.52551.66
Construction In Progress
13.9916.12131.3672.9540.99
Source: S&P Global Market Intelligence. Standard template. Financial Sources.